Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 31  •  11:14AM ET
15.97
Dollar change
-0.01
Percentage change
-0.06
%
IndexRUT P/E- EPS (ttm)-3.09 Insider Own8.37% Shs Outstand87.01M Perf Week1.78%
Market Cap1.39B Forward P/E- EPS next Y-2.37 Insider Trans0.07% Shs Float79.76M Perf Month39.23%
Enterprise Value1.13B PEG- EPS next Q-0.57 Inst Own85.32% Short Float19.10% Perf Quarter45.84%
Income-212.39M P/S110.41 EPS this Y57.86% Inst Trans8.73% Short Ratio12.24 Perf Half Y80.45%
Sales12.59M P/B5.16 EPS next Y-12.56% ROA-71.69% Short Interest15.24M Perf YTD50.38%
Book/sh3.09 P/C5.19 EPS next 5Y25.10% ROE-81.20% 52W High17.32 -7.78% Perf Year30.90%
Cash/sh3.08 P/FCF- EPS past 3/5Y-32.63% -38.15% ROIC-77.68% 52W Low5.15 210.09% Perf 3Y265.03%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin79.25% Volatility6.33% 7.90% Perf 5Y36.03%
Dividend TTM- EV/Sales89.45 EPS Y/Y TTM59.89% Oper. Margin-1513.45% ATR (14)1.03 Perf 10Y-
Dividend Ex-Date- Quick Ratio12.13 Sales Y/Y TTM16.74% Profit Margin-1687.08% RSI (14)60.85 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio12.13 EPS Q/Q17.24% SMA203.48% Beta1.97 Target Price24.00
Payout- Debt/Eq0.02 Sales Q/Q69.84% SMA5030.25% Rel Volume0.35 Prev Close15.98
Employees118 LT Debt/Eq0.02 EarningsAug 06 AMC SMA20062.14% Avg Volume1.24M Price15.97
IPOOct 02, 2020 Option/ShortYes / Yes EPS/Sales Surpr.3.23% 381.82% Trades Volume130,888 Change-0.06%
Date Action Analyst Rating Change Price Target Change
Sep-22-25Initiated Goldman Buy $26
Sep-05-25Initiated Craig Hallum Buy $26
Apr-02-25Initiated Lake Street Buy $23
Nov-08-24Initiated Stephens Overweight $30
May-31-24Initiated Piper Sandler Overweight $27
Apr-30-24Initiated JP Morgan Overweight $24
Apr-15-24Initiated Guggenheim Buy $35
Jan-29-24Initiated Leerink Partners Outperform $30
Dec-19-23Initiated Wedbush Outperform $12
Oct-29-21Initiated Cantor Fitzgerald Overweight $35
Oct-23-25 12:00PM
Oct-02-25 05:05PM
Sep-25-25 06:30AM
Sep-18-25 08:00AM
Sep-04-25 05:05PM
08:00AM Loading…
Sep-03-25 08:00AM
Aug-22-25 09:35AM
Aug-06-25 05:45PM
05:30PM
04:05PM
10:00AM
07:00AM
Aug-05-25 05:15PM
Aug-01-25 05:51PM
Jul-03-25 04:05PM
10:29AM Loading…
Jul-01-25 10:29AM
Jun-16-25 12:00PM
Jun-12-25 09:55AM
Jun-05-25 04:05PM
May-26-25 09:55AM
May-22-25 08:00AM
May-13-25 12:00PM
May-12-25 05:45PM
05:25PM
04:05PM
May-08-25 09:55AM
May-02-25 04:01PM
Apr-17-25 06:06AM
Apr-10-25 09:32AM
Apr-04-25 08:00AM
04:05PM Loading…
Apr-03-25 04:05PM
Mar-26-25 08:00PM
Mar-19-25 05:35PM
04:05PM
Mar-10-25 07:41AM
Mar-06-25 04:01PM
Feb-25-25 08:00AM
Feb-06-25 04:01PM
Jan-31-25 04:01PM
Jan-29-25 11:11PM
04:27PM
Jan-13-25 08:00AM
Jan-07-25 08:00AM
Jan-02-25 06:03PM
Dec-02-24 06:26PM
Nov-27-24 01:22PM
08:00AM
Nov-13-24 05:15PM
04:05PM
Nov-05-24 08:00AM
Nov-01-24 04:05PM
Oct-30-24 08:30AM
Oct-29-24 08:00AM
Oct-18-24 08:00AM
Oct-08-24 08:05AM
08:00AM
Sep-13-24 07:00AM
Aug-29-24 08:00AM
Aug-20-24 03:26PM
Aug-12-24 05:15PM
04:01PM
Jul-25-24 08:00AM
07:30AM
Jul-09-24 07:00AM
Jun-27-24 08:00AM
May-22-24 02:05PM
May-21-24 07:01PM
May-20-24 11:14AM
08:00AM
May-17-24 08:51AM
08:00AM
May-14-24 01:54PM
09:10AM
08:00AM
May-08-24 08:00AM
May-02-24 08:00AM
Apr-30-24 07:29AM
Apr-26-24 10:00AM
Apr-25-24 08:26AM
Apr-05-24 08:00AM
Mar-28-24 11:53PM
04:02PM
Mar-26-24 08:00AM
08:00AM
Mar-18-24 05:44AM
Mar-07-24 08:00AM
Mar-04-24 07:00AM
Mar-01-24 08:00AM
Feb-20-24 08:15AM
08:00AM
Feb-16-24 04:05PM
Feb-13-24 10:38PM
04:05PM
Feb-07-24 08:34AM
Feb-06-24 09:20AM
08:00AM
Feb-05-24 08:00AM
Jan-08-24 07:00AM
Jan-04-24 08:00AM
Jan-03-24 08:00AM
Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Higgins JackChief Scientific OfficerSep 10 '25Option Exercise1.3522,00029,70040,729Sep 11 09:04 PM
BIENAIME JEAN JACQUESDirectorJun 03 '25Buy9.385,00046,90036,415Jun 03 09:21 PM
Higgins JackChief Scientific OfficerMar 27 '25Option Exercise1.355,2007,02018,729Mar 28 05:54 PM
BIENAIME JEAN JACQUESDirectorMar 25 '25Buy7.787,80060,68431,415Mar 26 04:05 PM
SIEGALL CLAY BPresident and CEOMar 26 '25Buy7.29137,100999,459806,736Mar 26 04:03 PM
BIENAIME JEAN JACQUESDirectorMar 24 '25Buy8.217,00057,47023,615Mar 25 05:18 PM
Tsai PhilipChief Technology OfficerMar 24 '25Buy8.4212,300103,56633,300Mar 25 05:15 PM
SIEGALL CLAY BPresident and CEOJan 31 '25Buy7.75150,0001,162,500669,636Feb 03 09:01 PM
SIEGALL CLAY BPresident and CEONov 21 '24Buy9.5466,057630,263485,693Nov 25 08:41 AM
SIEGALL CLAY BPresident and CEONov 22 '24Buy9.7833,943331,918519,636Nov 25 08:41 AM
Lechleider RobertChief Medical OfficerNov 21 '24Buy9.4815,805149,80015,805Nov 25 08:35 AM
Tsai PhilipChief Technology OfficerNov 21 '24Buy9.4321,000198,03021,000Nov 25 08:33 AM